| Role of pharmacogenetics in public health and clinical health care: a SWOT analysis R Kapoor, WC Tan-Koi, YY Teo European Journal of Human Genetics 24 (12), 1651-1657, 2016 | 44 | 2016 |
| Cost–effectiveness analysis of genotyping for HLA-B*5801 and an enhanced safety program in gout patients starting allopurinol in Singapore D Dong, WC Tan-Koi, GG Teng, E Finkelstein, C Sung Pharmacogenomics 16 (16), 1781-1793, 2015 | 44 | 2015 |
| Pharmacovigilance activities in ASEAN countries W Suwankesawong, T Dhippayom, WC Tan‐Koi, C Kongkaew pharmacoepidemiology and drug safety 25 (9), 1061-1069, 2016 | 30 | 2016 |
| Applications of pharmacogenomics in regulatory science: a product life cycle review WC Tan-Koi, PC Leow, YY Teo The pharmacogenomics journal 18 (3), 359-366, 2018 | 17 | 2018 |
| Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach WC Tan-Koi, C Sung, YY Chong, A Lateef, SM Pang, A Vasudevan, D Aw, ... Pharmacogenomics 18 (9), 881-890, 2017 | 16 | 2017 |
| Health regulatory communications of well-established safety-related pharmacogenomics associations in six developed countries: an evaluation of alignment WC Tan-Koi, ESH Lim, YY Teo The pharmacogenomics journal 17 (2), 121-127, 2017 | 12 | 2017 |
| Post-vaccination abscesses requiring surgical drainage in a tertiary children’s hospital in Singapore NWH Tan, WJ Pan, HHBM Yunos, WC Tan, KBL Lim Journal of Pediatric Infectious Diseases 5 (02), 139-147, 2010 | 11 | 2010 |
| A cluster of Epoetin-associated pure red cell aplasia: clinical features and the possible association of HLA-DRB1*12:02 CW Tan, WC Tan-Koi, J Ng, CM Chan, WYK Hwang Pharmacogenomics 17 (11), 1235-1243, 2016 | 7 | 2016 |
| Is HLA-B* 58: 01 genotyping cost effective in guiding allopurinol use in gout patients with chronic kidney disease? GG Teng, WC Tan-Koi, D Dong, C Sung Pharmacogenomics 21 (4), 279-291, 2020 | 6 | 2020 |
| The importance of ethnicity definitions and pharmacogenomics in ethnobridging and pharmacovigilance WC Tan-Koi, M Limenta, EHM Mohamed, EJD Lee Pharmacogenomics, 289-327, 2019 | 6 | 2019 |
| Pharmacogenetics through a public health lens: from policy to practice WC Tan-Koi, R Kapoor, YY Teo Pharmacogenetics and Genomics 25 (10), 518-520, 2015 | 3 | 2015 |
| Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making YK Khoo, JCW Lim, WC Tan-Koi, NS Kitikiti, AL Sim-Devadas Drug Safety 47 (3), 217-225, 2024 | | 2024 |
